Physician profile
Bruce E Staley
NPI 1841283033
$1,052.23
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $260 · 2020: $40.92 · 2021: $209 · 2022: $491 · 2023: $35.77 · 2024: $15.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $51.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $51.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $172.72 | 2019-2022 | |
| Novo Nordisk INC | $125.96 | 2019-2023 | |
| Amarin Pharma, INC. | $92.51 | 2019-2021 | |
| Lilly USA, LLC | $85.40 | 2019-2023 | Mounjaro |
| Abbvie INC. | $65.76 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.21 | 2022 | |
| Janssen Pharmaceuticals, INC | $62.88 | 2021-2022 | |
| Astellas Pharma US INC | $62.23 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $54.96 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $48.54 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $42.01 | 2020-2022 | |
| Pulmonx Corporation | $35.26 | 2021 | |
| Glaxosmithkline, LLC. | $29.86 | 2022 | |
| Allergan, INC. | $24.84 | 2019 | |
| Abbott Laboratories | $21.13 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | $19.04 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.32 | 2019 | |
| Pfizer INC. | $15.54 | 2019 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $13.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Staley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.